Cold Laser vs Excimer Laser in Lower Limb Atherosclerosis
JACC: Cardiovascular Interventions · 2026
DOI: 10.1016/j.jcin.2026.02.036 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Hui Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Lasers, Excimer, Atherectomy, Lower Extremity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Science and Technology Commission.
Abstract (Originalsprache)
BACKGROUND: Peripheral artery disease (PAD) caused by atherosclerotic stenosis or occlusion of the arteries of the lower extremities is a major global health concern. Despite advances in endovascular therapies, treating complex lesions such as heavily calcified segments and chronic total occlusions remains challenging, which limits procedural success and long-term patency. The novel 355-nm cold laser atherectomy (CLA) system offers a photochemical, low-thermal approach to plaque ablation, with potential advantages in safety and efficacy. OBJECTIVES: The aim of this study was to evaluate the safety and efficacy of a 355-nm CLA system for treating lower limb atherosclerotic stenosis and occlusion in a prospective, multicenter, randomized controlled trial. METHODS: This trial enrolled 110 patients with symptomatic lower extremity PAD (Rutherford classes 2-5) and ≥70% stenosis or occlusion. Patients were randomly assigned to the CLA and excimer laser atherectomy (ELA) groups. The primary endpoint was improvement in vessel diameter stenosis (DS%) prior to any adjunctive therapy. Secondary endpoints included primary patency, target lesion revascularization (TLR), Rutherford classification improvement, and ankle-brachial index values at 30 days and 6 months postoperatively, as well as a device-oriented composite endpoint. RESULTS: A total of 109 patients (CLA, n = 58; ELA, n = 51) were included in the analysis. Baseline demographics and comorbidities were well balanced between the groups. Postprocedural DS% improved significantly in both groups, with no significant intergroup differences (CLA, 59.92% ± 15.02%; ELA, 57.52% ± 17.22%; P = 0.438). The mean improvement in DS% (CLA, 34.28%; ELA, 34.35%) met the noninferiority threshold. At 30 days, the primary patency rates were 85.1% (CLA) and 87.8% (ELA), with TLR rates of 0.0% and 1.9%, respectively. At 6 months, patency decreased to 71.7% (CLA) and 61.5% (ELA), and TLR occurred in 6.5% and 10.2% of patients, respectively (P = 0.698). Ankle-brachial index values and Rutherford classification improved similarly in the 2 groups. Subgroup analyses revealed that for TASC (Trans-Atlantic Inter-Society Consensus) C/D and long lesions (≥10 cm), CLA had lower TLR rates at 6 months (P < 0.05), suggesting potential advantages for complex lesions. CONCLUSIONS: The 355-nm CLA system showed similar safety and efficacy to the excimer laser, with a trend toward reducing TLR in complex PAD lesions. These findings highlight its potential as a next-generation endovascular tool that could refine revascularization strategies and improve patient outcomes in clinical practice. (DCB for Dialysis Access Stent Graft Restenosis; NCT03360279).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Vascular Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Vascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of Burns and Wound Repair Surgery, Guangdong Provincial People's Hospital, Guangdong, China.
- Department of Burns and Wound Repair Surgery, Guangdong Provincial People's Hospital, Guangdong, China; Department of Burns, Plastic and Wound Repair Surgery, Ganzhou Hospital, Guangdong Provincial People's Hospital, Ga…
- Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Electronic address: glrxuanwu@163.com.
Förderung
- Beijing Municipal Science and Technology Commission
Zitieren
APA
Wang, H., Qin, J., Liu, C., Gao, X., Ma, L., Cui, S., Lu, X., Lu, S., Huang, Z., Tong, Z., Guo, L., & Guo, J. (2026). Cold Laser vs Excimer Laser in Lower Limb Atherosclerosis. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2026.02.036
Vancouver
Wang H, Qin J, Liu C, Gao X, Ma L, Cui S, et al. Cold Laser vs Excimer Laser in Lower Limb Atherosclerosis. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2026.02.036
BibTeX
@article{Wang2026,
author = {Wang, Hui and Qin, Jinbao and Liu, Chao and Gao, Xixiang and Ma, Lianghua and Cui, Shijun and Lu, Xinwu and Lu, Shaoying and Huang, Zhifeng and Tong, Zhu and Guo, Lianrui and Guo, Jianming},
title = {Cold Laser vs Excimer Laser in Lower Limb Atherosclerosis},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
doi = {10.1016/j.jcin.2026.02.036}
}
EUVIMED